Andrew Clouston, the Managing Partner at Envoi is an anatomical pathologist with a special interest in gastrointestinal and hepatic pathology, for which he is recognised internationally, with an ongoing research interest in chronic hepatitis C, steatosis as a co-factor in liver disease progression and hepatic fibrosis mechanisms. Dr Clouston is also an Associate Professor of Pathology at the University of Queensland and an Associate Investigator at the University of Queensland Centre for Clinical Research. He has published extensively in journals that include Hepatology, Gastroenterology, Gut and Blood and has been an Investigator on grants from the NHMRC and NIH.
With Drs Julie Jonsson and Elizabeth Powell, he has helped to shape two new paradigms in liver disease; the importance of steatosis in the progression of chronic hepatitis C, and more recently proposing altered hepatic regeneration and the ductular reaction as a potential driver of hepatic fibrosis. These have resulted in Editorials in Hepatology and Gastroenterology, as well as invitations to write editorials and reviews related to these areas. International research collaborators include groups in USA, United Kingdom and Austria.
Dr Clouston is an invited member of the Laennec Society, an international study group in liver pathology and was recently invited to join the influential International Liver Study Group – the “Gnomes”. He has delivered over 100 invited lectures locally, nationally and internationally in the areas of liver and gastrointestinal disease and transplantation. These include lectures in the United Kingdom, USA, Canada, Greece and Japan. In 2007 he was an invited faculty member of the American Association for Study of Liver Disease Postgraduate Course (Boston), and also gave an AASLD Meet-The-Professor Lecture.
He has been the Royal College of Pathologists of Australasia nominee on the Australian National Bowel Cancer Screening Programme and is currently the Convenor of the Liver Companion Meetings of the International Academy of Pathology (Australasian Division). In 2004 he was the Convenor for Liver Pathology at the World Congress of the International Academy of Pathology, held in Australia and in 2005 the Co-Chair of the Banff Consensus Panel for Liver Allograft Pathology. He is actively involved in registrar teaching of Anatomical Pathology registrars in Queensland and New South Wales, is an examiner for the Royal Collage of Pathologists of Australiasia and provides consultation advice in liver-tumour and liver-disease pathology nationally.